FDA says Boston Scientific initiates recall of stent for leg arteries

06/20/2011 | Wall Street Journal, The

The FDA said Boston Scientific has voluntarily pulled from the market its Innova self-expanding stent, which is designed to treat lesions in leg arteries, after receiving reports of deployment problems that might lead to vessel wall injury and emergency surgery, among other adverse events. Boston Scientific, which markets the device outside the U.S., already has informed consumers about the stent problem.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX